Effects of Long-Acting Somatostatin Analogues on Lipid Metabolism in Patients with Newly Diagnosed Acromegaly: A Retrospective Study of 120 Cases
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Long-Acting Somatostatin Analogues on Lipid Metabolism in
Patients with Newly Diagnosed Acromegaly: A Retrospective Study of 120
Cases
Authors
Keywords
-
Journal
HORMONE AND METABOLIC RESEARCH
Volume 54, Issue 01, Pages 25-32
Publisher
Georg Thieme Verlag KG
Online
2022-01-06
DOI
10.1055/a-1717-9332
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic complications in acromegaly after neurosurgery: A meta-analysis.
- (2020) Alessia Cozzolino et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pegvisomant improves Glucose Metabolism in Acromegaly: a meta-analysis of prospective interventional studies
- (2019) Tiziana Feola et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Persistent inflammation and endothelial dysfunction in patients with treated acromegaly
- (2019) Thalijn Liliana Catharina Wolters et al. Endocrine Connections
- Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies
- (2018) Alessia Cozzolino et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cardiovascular Disease and Sleep-Disordered Breathing in Acromegaly
- (2015) Andrew S. Powlson et al. NEUROENDOCRINOLOGY
- The Metabolic Risk in Patients Newly Diagnosed with Acromegaly Is Related to Fat Distribution and Circulating Adipokines and Improves after Treatment
- (2015) Nicoleta C. Olarescu et al. NEUROENDOCRINOLOGY
- IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition
- (2015) Tirissa J. Reid et al. Pituitary
- The beneficial effect of acromegaly control on blood pressure values in normotensive patients
- (2014) Chiara Sardella et al. CLINICAL ENDOCRINOLOGY
- Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: A retrospective, comparative, head- to- head study
- (2014) R. S. Auriemma et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Three noninvasive methods in the evaluation of subclinical cardiovascular disease in patients with acromegaly: epicardial fat thickness, aortic stiffness and serum cell adhesion molecules
- (2013) Oya Topaloglu et al. CLINICAL ENDOCRINOLOGY
- Effects of Lanreotide Autogel on Growth Hormone, Insulinlike Growth Factor 1, and Tumor Size in Acromegaly: A 1-Year Prospective Multicenter Study
- (2013) Roberto Attanasio et al. Endocrine Practice
- A Comprehensive Study of Clinical, Biochemical, Radiological, Vascular, Cardiac, and Sleep Parameters in an Unselected Cohort of Patients With Acromegaly Undergoing Presurgical Somatostatin Receptor Ligand Therapy
- (2013) Anand K. Annamalai et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- GH levels and insulin sensitivity are differently associated with biomarkers of cardiovascular disease in active acromegaly
- (2012) L. Boero et al. CLINICAL ENDOCRINOLOGY
- Active acromegaly is associated with decreased hs-CRP and NT-proBNP serum levels: insights from the Belgian registry of acromegaly
- (2012) Johan Verhelst et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Evaluation of the Impact of Treatment on Endothelial Function and Cardiac Performance in Acromegaly
- (2010) Ebru Akgul et al. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
- Mortality in Patients with Pituitary Disease
- (2010) Mark Sherlock et al. ENDOCRINE REVIEWS
- Acromegaly per se does not increase the risk for coronary artery disease
- (2010) Hiroyoshi Akutsu et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Growth hormone status predicts left ventricular mass in patients after cure of acromegaly
- (2010) Tamara L. Wexler et al. GROWTH HORMONE & IGF RESEARCH
- Cardiovascular Risk Factors in Patients with Uncontrolled and Long-Term Acromegaly: Comparison with Matched Data from the General Population and the Effect of Disease Control
- (2010) Christian Berg et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Consensus on Criteria for Cure of Acromegaly
- (2010) A. Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: Relation to growth hormone levels and insulin-like growth factor I
- (2009) J. Wildbrett et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Effects of Initial Therapy for Five Years with Somatostatin Analogs for Acromegaly on Growth Hormone and Insulin-Like Growth Factor-I Levels, Tumor Shrinkage, and Cardiovascular Disease: A Prospective Study
- (2009) Annamaria Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Amelioration of cardiovascular risk factors with partial biochemical control of acromegaly
- (2008) Sideris P. Delaroudis et al. CLINICAL ENDOCRINOLOGY
- Alterations in biomarkers of cardiovascular disease (CVD) in active acromegaly
- (2008) L. Boero et al. CLINICAL ENDOCRINOLOGY
- Impact of Treating Acromegaly First with Surgery or Somatostatin Analogs on Cardiomyopathy
- (2008) Annamaria Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search